Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study.

PloS one

Volumn 7, Issue 4, 2012, Pages

  Iaffaldano, Pietro ^a   Viterbo, Rosa Gemma ^b   Paolicelli, Damiano ^b   Lucchese, Guglielmo ^b   Portaccio, Emilio ^b   Goretti, Benedetta ^b   Direnzo, Vita ^b   D'Onghia, Mariangela ^b   Zoccolella, Stefano ^b   Amato, Maria Pia ^b   Trojano, Maria ^b  

^a UNIVERSITY OF BARI   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; NATALIZUMAB;

ADULT; ARTICLE; COGNITION; DRUG ADMINISTRATION; DRUG EFFECT; FATIGUE; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; RECURRENT DISEASE;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; COGNITION; DRUG ADMINISTRATION SCHEDULE; FATIGUE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; RECURRENCE; SEVERITY OF ILLNESS INDEX;

EID: 84866177950     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035843     Document Type: Article

References (0)